Skip to content

Stereotaxis STXS Financing Cash Flow

Financing Cash Flow at other companies

Abbott logo
AbbottABT
$17.31B+942%
Boston Scientific logo
Boston ScientificBSX
-$260M-212%
Medtronic logo
MedtronicMDT
-$888M+33.9%
Stryker logo
StrykerSYK
-$1.51B-160%
ITG
Integer HoldingsITGR
$3.83M-97.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$6.29M-190%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's financing cash flow?
Stereotaxis (STXS) reported financing cash flow of $4.72M in Q1 2026.
How has Stereotaxis's financing cash flow changed year-over-year?
Stereotaxis's financing cash flow increased by 14637.5% year-over-year, from $32K to $4.72M.
What is the long-term trend for Stereotaxis's financing cash flow?
Over 3 years (2021 to 2025), Stereotaxis's financing cash flow has grown at a 200.0% compound annual growth rate (CAGR), from $547K to $14.76M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.